238 related articles for article (PubMed ID: 20091141)
1. Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models.
Asikainen S; Rudgalvyte M; Heikkinen L; Louhiranta K; Lakso M; Wong G; Nass R
J Mol Neurosci; 2010 May; 41(1):210-8. PubMed ID: 20091141
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
[TBL] [Abstract][Full Text] [Related]
3. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
4. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M
Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053
[TBL] [Abstract][Full Text] [Related]
5. Multiple checkpoints of protein clearance machinery are modulated by a common microRNA, miR-4813-3p, through its putative target genes: Studies employing transgenic C. elegans model.
Sarkar A; Shamsuzzama ; Kumar L; Hameed R; Nazir A
Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119342. PubMed ID: 35998789
[TBL] [Abstract][Full Text] [Related]
6. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
Wei CC; Chang CH; Liao VH
Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
[TBL] [Abstract][Full Text] [Related]
7. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of α-synuclein protein at Ser-129 reduces neuronal dysfunction by lowering its membrane binding property in Caenorhabditis elegans.
Kuwahara T; Tonegawa R; Ito G; Mitani S; Iwatsubo T
J Biol Chem; 2012 Mar; 287(10):7098-109. PubMed ID: 22232559
[TBL] [Abstract][Full Text] [Related]
9. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
[TBL] [Abstract][Full Text] [Related]
10. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
[TBL] [Abstract][Full Text] [Related]
11. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
[TBL] [Abstract][Full Text] [Related]
12. Ida-1, the Caenorhabditis elegans orthologue of mammalian diabetes autoantigen IA-2, potentially acts as a common modulator between Parkinson's disease and Diabetes: role of Daf-2/Daf-16 insulin like signalling pathway.
Fatima S; Haque R; Jadiya P; Shamsuzzama ; Kumar L; Nazir A
PLoS One; 2014; 9(12):e113986. PubMed ID: 25469508
[TBL] [Abstract][Full Text] [Related]
13. TDP-1/TDP-43 potentiates human α-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans.
Shen L; Wang C; Chen L; Leung KL; Lo E; Lakso M; Wong G
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165876. PubMed ID: 32531261
[TBL] [Abstract][Full Text] [Related]
14. Functional implications of NHR-210 enrichment in C. elegans cephalic sheath glia: insights into metabolic and mitochondrial disruptions in Parkinson's disease models.
Hameed R; Naseer A; Saxena A; Akbar M; Toppo P; Sarkar A; Shukla SK; Nazir A
Cell Mol Life Sci; 2024 May; 81(1):202. PubMed ID: 38691171
[TBL] [Abstract][Full Text] [Related]
15. Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu Y; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ
Brain; 2019 Sep; 142(9):2845-2859. PubMed ID: 31312839
[TBL] [Abstract][Full Text] [Related]
16. Degradome sequencing reveals an endogenous microRNA target in C. elegans.
Park JH; Ahn S; Kim S; Lee J; Nam JW; Shin C
FEBS Lett; 2013 Apr; 587(7):964-9. PubMed ID: 23485825
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variation in Complex Traits in Transgenic α-Synuclein Strains of
Wang YA; van Sluijs L; Nie Y; Sterken MG; Harvey SC; Kammenga JE
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32664512
[TBL] [Abstract][Full Text] [Related]
18. Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans.
Kuwahara T; Koyama A; Gengyo-Ando K; Masuda M; Kowa H; Tsunoda M; Mitani S; Iwatsubo T
J Biol Chem; 2006 Jan; 281(1):334-40. PubMed ID: 16260788
[TBL] [Abstract][Full Text] [Related]
19. The conserved miR-51 microRNA family is redundantly required for embryonic development and pharynx attachment in Caenorhabditis elegans.
Shaw WR; Armisen J; Lehrbach NJ; Miska EA
Genetics; 2010 Jul; 185(3):897-905. PubMed ID: 20421599
[TBL] [Abstract][Full Text] [Related]
20. Target-mediated protection of endogenous microRNAs in C. elegans.
Chatterjee S; Fasler M; Büssing I; Grosshans H
Dev Cell; 2011 Mar; 20(3):388-96. PubMed ID: 21397849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
